About Medicus Pharma
Medicus Pharma is a company based in Toronto (Canada) founded in 2008. Medicus Pharma has completed 1 acquisition, including Antev. Medicus Pharma offers products and services including Skin Cancer Treatment Regimen. Medicus Pharma operates in a competitive market with competitors including PPD, Cambrian BioPharma, H.U. Group Holdings, DM Clinical and IPHARMA, among others.
- Headquarter Toronto, Canada
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medicus Pharma Ltd.
-
Annual Revenue
Not available
-
Net Profit
-$8.14 M (USD)-106.79as on Dec 31, 2024
-
EBITDA
-$8.16 M (USD)-132.89as on Dec 31, 2024
-
Latest Funding Round
$11.02 M (USD), Post-IPO
May 03, 2024
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Medicus Pharma
Medicus Pharma is a publicly listed company on the NASDAQ with ticker symbol MDCX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Medicus Pharma
Medicus Pharma offers a comprehensive portfolio of products and services, including Skin Cancer Treatment Regimen.
Non-invasive regimen for treating skin cancer via clinical programs.
People of Medicus Pharma
Unlock access to complete
Unlock access to complete
Funding Insights of Medicus Pharma
Investments & Acquisitions by Medicus Pharma
Medicus Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Antev.
Investment portfolio details for Medicus Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
GnRH antagonists for urology indications in humans & animals
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for Medicus Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Medicus Pharma
Detailed financials for Medicus Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medicus Pharma Comparisons
Peer comparison for Medicus Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medicus Pharma
Medicus Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PPD, Cambrian BioPharma, H.U. Group Holdings, DM Clinical and IPHARMA, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CRO providing diversified clinical development services
|
|
| Locked | Locked | Locked |
Medicines and therapies are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Provider of clinical testing, diagnostics, and healthcare services. This entity offers a range of services encompassing laboratory testing and related services, in-vitro diagnostics, healthcare-related services, and research and development. Their activities include supporting research in clinical laboratory medicine, fostering technological advancements, and contributing to the overall progress of medical science and healthcare technology. They also engage in intellectual property activities and have initiatives addressing public health concerns.
|
|
| Locked | Locked | Locked |
Conducts Phase I-IV clinical trials connecting patients with physicians for medical research.
|
|
| Locked | Locked | Locked |
Serves as a contract research organization focused on drug clinical trials.
|
Detailed competitors of Medicus Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medicus Pharma
Complete news archive for Medicus Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medicus Pharma
Medicus Pharma was founded in 2008 and raised its 1st funding round 16 years after it was founded.
Medicus Pharma is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Raza Bokhari is the current CEO of Medicus Pharma.
Medicus Pharma Ltd. is a clinical stage, multi-strategy holding company focused on investing in and accelerating novel therapies. They are involved in biotechnology research and accelerate life sciences and bio-technology companies through FDA clinical trials.
Medicus Pharma's top competitors include PPD, Cambrian BioPharma and H.U. Group Holdings.
Medicus Pharma offers Skin Cancer Treatment Regimen.
Yes, Medicus Pharma is publicly traded on NASDAQ under the ticker symbol MDCX.
Medicus Pharma has made 1 acquisition, including Antev.
The ticker symbol of Medicus Pharma is MDCX on NASDAQ.